Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.185    0.00 (0.00%)
Bid:
0.18
Ask:
0.19
Spread: 0.01 (5.556%)
Market Cap: £1.37m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

ValiRx News

ValiRx terminates exclusive negotiations with TheoremRx
3 Apr 2025

ValiRx terminates exclusive negotiations with TheoremRx

(Sharecast News) - ValiRx announced the immediate termination of its letter of intent with TheoremRx on Thursday, ending exclusive negotiations origin...

LONDON MARKET OPEN: Europe, Asia down as investors digest US tariffs
3 Apr 2025

LONDON MARKET OPEN: Europe, Asia down as investors digest US tariffs

(Alliance News) - London stocks slumped alongside Asian and European peers at Thursday's market open, as US tariff announcements and the prospect of t...

ValiRx shares fall as ends collaboration with Imperial College London
24 Feb 2025

ValiRx shares fall as ends collaboration with Imperial College London

(Alliance News) - ValiRx PLC on Monday said it has decided to return the Dual Kinase project to Imperial College London for further development, and w...

ValiRx's Inaphaea inks deal with UK-based Screenin3D
3 Feb 2025

ValiRx's Inaphaea inks deal with UK-based Screenin3D

(Sharecast News) - ValiRx announced on Monday that its wholly-owned subsidiary Inaphaea BioLabs has signed an evaluation and commercial use agreement ...

ValiRx enters evaluation and option deal with Canada's Altus
29 Jan 2025

ValiRx enters evaluation and option deal with Canada's Altus

(Sharecast News) - ValiRx announced on Wednesday that it has entered into an evaluation and option agreement with Canada-based Altus Formulation to as...

ValiRx further extends letter of intent with TheoremRx
31 Dec 2024

ValiRx further extends letter of intent with TheoremRx

(Sharecast News) - ValiRx, a life science company specialising in early-stage cancer therapeutics and women's health, announced a further amendment to...

AIM WINNERS & LOSERS: Strong 2024 for Quadrise and Rosebank
31 Dec 2024

AIM WINNERS & LOSERS: Strong 2024 for Quadrise and Rosebank

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.

ValiRx extends TheoremRx exclusivity period to final May 31 deadline
31 Dec 2024

ValiRx extends TheoremRx exclusivity period to final May 31 deadline

(Alliance News) - ValiRx PLC on Tuesday said it has extended the exclusivity period for a proposed sub-license agreement with TheoremRx Inc for its VA...